Cargando…
A double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patients
OBJECTIVE: To confirm the morphine to hydromorphone conversion ratio for hydromorphone (DS-7113b) immediate-release tablets in cancer patients who achieved pain control with oral morphine. METHODS: This was a multicenter, active-controlled, randomized, double-blind, parallel-group, comparative study...
Autores principales: | Inoue, Satoshi, Saito, Yoji, Tsuneto, Satoru, Aruga, Etsuko, Ogata, Takeshi, Uemori, Mitsutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926545/ https://www.ncbi.nlm.nih.gov/pubmed/29635632 http://dx.doi.org/10.1093/jjco/hyy046 |
Ejemplares similares
-
A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients
por: Inoue, Satoshi, et al.
Publicado: (2018) -
A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)
por: Inoue, Satoshi, et al.
Publicado: (2017) -
Hydromorphone/lorazepam/morphine overdose: Coma: case report
Publicado: (2019) -
A randomized, double-blind comparison of OROS(® )hydromorphone and controlled-release morphine for the control of chronic cancer pain
por: Hanna, Magdi, et al.
Publicado: (2008) -
Patient-controlled analgesia in the pediatric population: morphine versus hydromorphone
por: DiGiusto, Matthew, et al.
Publicado: (2014)